ProductsBack/CD19 antibody [HIB19] (PE)

FACS analysis of human peripheral blood lymphocytes using GTX01455-08 CD19 antibody [HIB19] (PE). Solid lone : primary antibody Dashed line : isotype control antibody amount : 0.25 microg (5 microl)

CD19 antibody [HIB19] (PE)

GTX01455-08

ApplicationsFlow Cytometry

DownloadDatasheet

Product group Antibodies

TargetCD19

Overview

Supplier
GeneTex
Product Name
CD19 antibody [HIB19] (PE)
Delivery Days Customer
9
Application Supplier Note
FACS: 0.25 microg (5 microl) for 105-108 cells in 100 microl sample per test. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
Flow Cytometry
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
HIB19
Concentration
0.05 mg/ml
Conjugate
RPE
Gene ID930
Target name
CD19
Target description
CD19 molecule
Target synonyms
B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; CVID3; differentiation antigen CD19; T-cell surface antigen Leu-12
Host
Mouse
Isotype
IgG1
Protein IDP15391
Protein Name
B-lymphocyte antigen CD19
Scientific Description
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq, Jul 2008]
Storage Instruction
2°C to 8°C
UNSPSC
12352203

References

Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans. Richards KA et al., 2020, NPJ Vaccines
Read more
Natural killer cell phenotype is altered in HIV-exposed seronegative women. Zhao NQ et al., 2020, PLoS One
Read more
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency. Stoszko M et al., 2020 Aug, Sci Adv
Read more
Activation of Toll-Like Receptors Differentially Modulates Inflammation in the Human Reproductive Tract: Preliminary Findings. Benjelloun F et al., 2020, Front Immunol
Read more
CD70 Deficiency Associated With Chronic Epstein-Barr Virus Infection, Recurrent Airway Infections and Severe Gingivitis in a 24-Year-Old Woman. Krueger R et al., 2020, Front Immunol
Read more
IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection. Bezie S et al., 2020, Front Immunol
Read more
Interferon-alpha alters host glycosylation machinery during treated HIV infection. Giron LB et al., 2020 Sep, EBioMedicine
Read more
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function. Salzer B et al., 2020 Aug 20, Nat Commun
Read more
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model. Kreye J et al., 2020 Aug 16, bioRxiv
Read more
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. Pierini S et al., 2020 Aug 20, JCI Insight
Read more

CD19 antibody [HIB19] (PE)

Large volume orders?

Overview

References

Related products